Mark Asset Management’s Eli Lilly LLY Stock Holding History

Mark Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,918	Closed	-$15.5M	–	61
2024 Q1	$15.5M	Buy	+19,918	New	+$14.2M	2.02%	20

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mark Asset Management's LLY Position: Q2 2024 in Review

Mark Asset Management sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 19,918 shares — an estimated $15.5M sold.

Mark Asset Management first reported a position in LLY in Q1 2024 and held it in 1 quarter. The position peaked at $15.5M in Q1 2024. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

Mark Asset Management reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
Mark Asset Management sold 19,918 Eli Lilly shares in Q2 2024, an estimated $15.5M.
Mark Asset Management first reported a position in Eli Lilly in Q1 2024 and held it in 1 quarter.
Mark Asset Management's Eli Lilly position peaked at $15.5M in Q1 2024.
3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Mark Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.